Posts tagged Antitrust Law
Open Markets Institute Files Second Amicus Brief Supporting FTC’s Nationwide Ban on Non-Compete Clauses

The Open Markets Institute filed an amicus brief in Ryan v. FTC, marking the second appellate case in which Open Markets has defended the Federal Trade Commission’s (FTC) landmark prohibition on non-compete clauses.

Read More
Open Markets Urges European Commission to Investigate Nvidia’s Planned Acquisition of Run:ai

The Open Markets Institute, alongside eight partner organizations, has made a detailed submission to the European Commission, urging it to fully investigate U.S. chipmaker Nvidia’s planned acquisition of workload management startup Run:ai.

Read More
Open Markets Institute Statement on the FTC’s Lawsuit Reviving the Robinson-Patman Act

In response to the Federal Trade Commission initiating a lawsuit against Southern Glazer’s Wine and Spirits, LLC for engaging in unlawful price discrimination, the Open Market Institute's senior legal analyst Daniel Hanley issued a statement.

Read More
Open Markets Urges Third Circuit to Hold Merck to Account for Lying to FDA as a Means of Preserving Mumps Vaccine Monopoly

The Open Markets Institute filed an amicus brief with the U.S. Court of Appeals for the Third Circuit, urging the court to grant a rehearing In re Merck Mumps Vaccine Antitrust Litigation. A class of physicians alleged that Merck misled the Food and Drug Administration about the shelf-life of its vaccine and thereby kept out a competing vaccine.

Read More
Open Markets Submits Comments to FTC Calling for Termination of 2012 Coopharma Consent Order

Open Markets submitted a comment to the FTC calling for termination of a 2012 Coopharma consent order and urging the agency to endorse an exemption for employees, contractors and small firms that challenge concentrations of power.

Read More